Post job

ReveraGen BioPharma's revenue is $4.2 million.

What is ReveraGen BioPharma's revenue?

ReveraGen BioPharma's annual revenue is $4.2M. Zippia's data science team found the following key financial metrics about ReveraGen BioPharma after extensive research and analysis.
  • ReveraGen BioPharma has 75 employees, and the revenue per employee ratio is $56,000.
  • ReveraGen BioPharma peak revenue was $4.2M in 2024.

On this page

Peak revenue
$4.2M (2024)
Company peak revenue
Revenue / employee
$56,000
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$4.2M (2024)
Company peak revenue
Revenue / employee
$56,000
Company revenue / employee

ReveraGen BioPharma financing

ReveraGen BioPharma received early financing of $800.0K on 2018-02-23.

SeriesRound sizeDate
Debt Financing$800K02/2018

ReveraGen BioPharma competitors

ReveraGen BioPharma's top competitor, zenColor, earned an annual revenue of $10.0M.

ReveraGen BioPharma's smallest competitor is Pagoda Box with revenue of $284.9K last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
Zagace-$5.1M350-
Speak Agent-$390,0009-
zenColor-$10.0M50-
VacationView-$690,00050-
Peerform-$4.0M2-
eRelyx-$700,0007-
nCrypted Cloud-$340,0006-
Codoxo-$2.5M30-
Visual Labs-$460,00011-
Pagoda Box-$284.9K5-

ReveraGen BioPharma revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of ReveraGen BioPharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about ReveraGen BioPharma. The employee data is based on information from people who have self-reported their past or current employments at ReveraGen BioPharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by ReveraGen BioPharma. The data presented on this page does not represent the view of ReveraGen BioPharma and its employees or that of Zippia.

ReveraGen BioPharma may also be known as or be related to ReveraGen BioPharma, ReveraGen BioPharma Inc, ReveraGen BioPharma Inc. and ReveraGen BioPharma, Inc.